Maureen Dubreuil, MD, M.Sc.

My interest is in the epidemiology of rheumatic diseases, with an emphasis on spondyloarthritis. Previous work has included study of risk factors for gout, and comorbidities of rheumatic diseases, and adverse events with nonsteroidal anti-inflammatory medications.

Under the mentorship of Drs. Neogi, Felson and Choi, I was awarded a project grant from the Arthritis Foundation to describe the association of ankylosing spondylitis with cardiovascular disease, and to understand possible mechanisms for the associations. This work revealed an increased risk of myocardial infarction with use of NSAIDs, which I presented at national and international conferences. My future work will continue to focus on adverse events with medication, including an assessment of factors that lead spondyloarthritis patients to select a medication, and a cost-effectiveness analysis including patient values, side effects, and costs of treatment for spondyloarthritis.

Answering these questions has the potential to improve longevity and quality of life for patients with rheumatic diseases, though a better understanding of the factors most important to patients. With my background in research, clinical training in rheumatology, rigorous research environment in the section of Clinical Epidemiology, and my mentoring team, I hope to continue my development as an independent clinical researcher with a focus on inflammatory rheumatic diseases.

Active Staff Hospital Privileges
Boston Medical Center

VA Boston Healthcare System

2014-2015 Boston University: Academy for Faculty Advancement Participant
2013-2015 Arthritis Foundation: Research Scientist Development Award
2013 BU Women's Guild Scholarship
2009 Gold Humanism in Medicine Award
2006 Waterbury Medical Association: Welsford and Mildred Clark Medical Memorial Scholarship

Establishing The Value of Treatment Strategies in Spondyloarthritis
05/01/2016 - 04/30/2018 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases

Cardiovascular disease and diabetes in Ankylosing Spondylitis
07/01/2013 - 12/30/2015 (PI)
Arthritis Foundation

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Oza A, Lu N, Schoenfeld SR, Fisher MC, Dubreuil M, Rai SK, Zhang Y, Choi HK. Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study. Ann Rheum Dis. 2017 Jul 11. PMID: 28698231.
  2. Deodhar AA, Kumthekar A, Dubreuil M. Minimal disease activity in axial spondyloarthritis: the need of the hour and a proposal for development. Curr Opin Rheumatol. 2017 Jul; 29(4):293-297. PMID: 28376060; DOI: 10.1097/BOR.0000000000000387;.
  3. Dubreuil M, Deodhar AA. Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol. 2017 Jul; 29(4):317-322. PMID: 28376062; DOI: 10.1097/BOR.0000000000000402;.
  4. Jutkowitz E, Dubreuil M, Lu N, Kuntz KM, Choi HK. The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States. Semin Arthritis Rheum. 2017 Apr; 46(5):594-600. PMID: 27916277; DOI: 10.1016/j.semarthrit.2016.10.009;.
  5. Zhang Y, Lu N, Peloquin C, Dubreuil M, Neogi T, Aviña-Zubieta JA, Rai SK, Choi HK. Improved survival in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis. 2017 Feb; 76(2):408-413.View Related Profiles. PMID: 27338777; DOI: 10.1136/annrheumdis-2015-209058;.
  6. Jinno S, Hasegawa K, Neogi T, Goto T, Dubreuil M. Trends in Emergency Department Visits and Charges for Gout in the United States between 2006 and 2012. J Rheumatol. 2016 Aug; 43(8):1589-92.View Related Profiles. PMID: 27252429; DOI: 10.3899/jrheum.151432;.
  7. Lee T, Lu N, Felson DT, Choi HK, Dalal DS, Zhang Y, Dubreuil M. Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study. Rheumatology (Oxford). 2016 Jun; 55(6):1099-105.View Related Profiles. PMID: 26983451; DOI: 10.1093/rheumatology/kew036;.
  8. Dubreuil M, Peloquin C, Zhang Y, Choi HK, Inman RD, Neogi T. Validity of ankylosing spondylitis diagnoses in The Health Improvement Network. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):399-404.View Related Profiles. PMID: 26762622; PMCID: PMC4826861; DOI: 10.1002/pds.3952;.
  9. Lee T, Lu N, Felson DT, Choi HK, Dalal D, Zhang Y, Dubreuil M. Use of NSAIDs Correlates with the Risk of Venous Thromboembolism in Knee OA Patients: A UK Population-Based Case-Control Study. Rheumatology (Oxford). 2015; Accepted for publication.
  10. Dubreuil M, Peloquin C, Zhang Y, Choi HK, Inman RD, Neogi T. Validity of Ankylosing Spondylitis Diagnoses in The Health Improvement Network. Pharmacoepidemiology and Drug Safety. 2015; Accepted for publication.
Showing 10 of 20 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 20 publications over 8 distinct years, with a maximum of 5 publications in 2016


I have mentored Master-level SPH students and fellows in projects related to epidemiology of rheumatologic diseases and pharmacoepidemiology. These projects have culminated in publications, a Master degree thesis, as well as poster and oral presentations at national meetings. I hope to continue mentoring trainees who have interests in epidemiology related to specific research projects, development of research themes, or development of grant applications.

Available to Mentor as: (Review Mentor Role Definitions):
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map

Dubreuil's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department